Talk to us?
Talk to us?
Coagulation Analyzer ZCOA-A12 processes up to 200 tests per hour, eliminating downtime with 1000 continuous cuvettes and synchronized motion manipulators. It offers high linearity (≥0.980 correlation coefficient) with a wide FIB testing range of 0.3-12g/L. Equipped with independent sample and reagent probes, along with automatic pre-heating and liquid surface detection. Our device ensures minimal interference from icterus, hemolysis, or plasma viscosity, guaranteeing highly precise and consistent outcomes.
| Testing Throughput | Up to 200 tests per hour (single item), 30 samples per hour (mixed tests) |
| Testing Method | Inductive dual magnetic circuit method with eddy current sensor |
| Testing Items | PT, APTT, FIB, TT, AT-III, HEP, LMWH, PC, PS, and other coagulation factors |
| Precision (CV) | <3% for highly accurate results |
| Temperature Control | 16°C reagent storage, 37°C thermostatic control for testing & pre-heating |
| Motion Mechanism | Synchronized X, Y, Z manipulators; high-speed cuvette feeding |
| Cuvettes Capacity | 1000 continuous units/load for uninterrupted operation |
| Probes | Independent sample and reagent probes with liquid surface detection |
| Pre-heating Positions | 10 positions for efficient sample preparation |
| Reagent Positions | 6 positions with cooling and stirring ability |
| Sample Positions | 30 interchangeable and extensible positions |
| Data Transmission | Dual-way HIS/LIS supported for seamless integration |
| Port Connectivity | USB and RS232 compatibility |
High throughput and efficiency
Advanced testing technology
Intelligent sample and reagent handling
High-speed motion mechanism
Accurate temperature control
Seamless automation
User-friendly operation
Advanced connectivity and reporting
Coagulation Analyzer ZCOA-A12 is an advanced, fully automated diagnostic instrument designed for clinical laboratories, hospitals, and research facilities to perform high-precision blood coagulation testing, enabling fast, reliable detection of clotting disorders, monitoring of anticoagulant therapies, and comprehensive hemostasis analysis with minimal manual intervention.
